It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Plasmodium ovale curtisi (Poc) and Plasmodium ovale wallikeri (Pow) are relapsing malaria parasites endemic to Africa and Asia that were previously thought to represent a single species. Amid increasing detection of ovale malaria in sub-Saharan Africa, we present a population genomic study of both species across the continent. We conducted whole-genome sequencing of 25 isolates from Central and East Africa and analyzed them alongside 20 previously published African genomes. Isolates are predominantly monoclonal (43/45), with their genetic similarity aligning with geography. Pow shows lower average nucleotide diversity (1.8×10−4) across the genome compared to Poc (3.0×10−4) (p < 0.0001). Signatures of selective sweeps involving the dihydrofolate reductase gene have been found in both species, as are signs of balancing selection at the merozoite surface protein 1 gene. Differences in the nucleotide diversity of Poc and Pow may reflect unique demographic history, even as similar selective forces facilitate their resilience to malaria control interventions.
Genomic analyses, performed by Carey-Ewend et al., reveal that Plasmodium ovale curtisi and wallikeri in sub-Saharan Africa show similar low complexity of infection, relatedness by geography, and signatures of selection. However, P. ovale wallikeri harbors lower nucleotide diversity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 University of North Carolina, Department of Epidemiology, Gillings School of Global Public Health, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208)
2 University of North Carolina, Institute for Global Health and Infectious Diseases, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208)
3 Brown University, Department of Pathology and Laboratory Medicine, Providence, USA (GRID:grid.40263.33) (ISNI:0000 0004 1936 9094)
4 Ethiopian Public Health Institute, Addis Ababa, Ethiopia (GRID:grid.452387.f) (ISNI:0000 0001 0508 7211)
5 SANRU Asbl, Kinshasa, Democratic Republic of the Congo (GRID:grid.463590.d)
6 Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo (GRID:grid.9783.5) (ISNI:0000 0000 9927 0991)
7 University of Massachusetts, Program in Molecular Medicine, Chan Medical School, Worcester, USA (GRID:grid.266684.8) (ISNI:0000 0001 2184 9220)
8 London School of Hygiene and Tropical Medicine, London, UK (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X)
9 National Institute for Medical Research (NIMR), Dar es Salaam, Tanzania (GRID:grid.416716.3) (ISNI:0000 0004 0367 5636); Kampala International University in Tanzania, Department of Biochemistry, Dar es Salaam, Tanzania (GRID:grid.470959.6)
10 University of Dschang, Department of Biochemistry, Faculty of Science, Dschang, Cameroon (GRID:grid.8201.b) (ISNI:0000 0001 0657 2358)
11 Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania (GRID:grid.25867.3e) (ISNI:0000 0001 1481 7466)
12 University of North Carolina, Institute for Global Health and Infectious Diseases, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208); University of North Carolina, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, USA (GRID:grid.410711.2) (ISNI:0000 0001 1034 1720); University of North Carolina, Curriculum in Genetics and Molecular Biology, University of North Carolina School of Medicine, Chapel Hill, USA (GRID:grid.410711.2) (ISNI:0000 0001 1034 1720)
13 University of North Carolina, Department of Epidemiology, Gillings School of Global Public Health, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208); University of North Carolina, Institute for Global Health and Infectious Diseases, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208); University of North Carolina, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, USA (GRID:grid.410711.2) (ISNI:0000 0001 1034 1720); University of North Carolina, Curriculum in Genetics and Molecular Biology, University of North Carolina School of Medicine, Chapel Hill, USA (GRID:grid.410711.2) (ISNI:0000 0001 1034 1720)
14 University of North Carolina, Institute for Global Health and Infectious Diseases, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208); University of North Carolina, Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, USA (GRID:grid.410711.2) (ISNI:0000 0001 1034 1720); University of North Carolina, Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, USA (GRID:grid.410711.2) (ISNI:0000 0001 1034 1720)